ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
BIT:1LLY - US5324571083 - Common Stock
635.6 EUR
+5.7 (+0.9%)
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 50 industry peers in the Pharmaceuticals industry. 1LLY has an excellent profitability rating, but there are some minor concerns on its financial health. 1LLY shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
1LLY had positive earnings in the past year.
1LLY had a positive operating cash flow in the past year.
Each year in the past 5 years 1LLY has been profitable.
1LLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 1LLY (13.67%) is better than 86.00% of its industry peers.
Looking at the Return On Equity, with a value of 75.52%, 1LLY belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 29.63%, 1LLY belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
1LLY had an Average Return On Invested Capital over the past 3 years of 21.71%. This is significantly above the industry average of 15.31%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(29.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROIC | 29.63% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
With an excellent Profit Margin value of 25.91%, 1LLY belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Profit Margin of 1LLY has declined.
Looking at the Operating Margin, with a value of 42.13%, 1LLY belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
In the last couple of years the Operating Margin of 1LLY has grown nicely.
1LLY has a better Gross Margin (82.64%) than 86.00% of its industry peers.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
1LLY has less shares outstanding than it did 5 years ago.
1LLY has a worse debt/assets ratio than last year.
2.2 Solvency
1LLY has an Altman-Z score of 6.72. This indicates that 1LLY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.72, 1LLY belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
1LLY has a Debt/Equity ratio of 1.87. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.87, 1LLY is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.72 |
ROIC/WACC2.99
WACC9.9%
2.3 Liquidity
A Current Ratio of 1.28 indicates that 1LLY should not have too much problems paying its short term obligations.
1LLY has a Current ratio of 1.28. This is comparable to the rest of the industry: 1LLY outperforms 48.00% of its industry peers.
A Quick Ratio of 1.00 indicates that 1LLY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, 1LLY is in line with its industry, outperforming 56.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 77.67% over the past year.
Measured over the past years, 1LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
Looking at the last year, 1LLY shows a very strong growth in Revenue. The Revenue has grown by 36.83%.
Measured over the past years, 1LLY shows a quite strong growth in Revenue. The Revenue has been growing by 15.08% on average per year.
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
3.2 Future
The Earnings Per Share is expected to grow by 30.54% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1LLY will show a quite strong growth in Revenue. The Revenue will grow by 17.75% on average per year.
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.54%
Revenue Next Year36.89%
Revenue Next 2Y27.13%
Revenue Next 3Y23.54%
Revenue Next 5Y17.75%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 45.83, 1LLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 62.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. 1LLY is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 24.25, which indicates a rather expensive current valuation of 1LLY.
Based on the Price/Forward Earnings ratio, 1LLY is valued a bit more expensive than 62.00% of the companies in the same industry.
1LLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.63.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.83 | ||
| Fwd PE | 24.25 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than the industry average as 66.00% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 30.28 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of 1LLY may justify a higher PE ratio.
A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 42.28% in the coming years.
PEG (NY)0.6
PEG (5Y)2.77
EPS Next 2Y53.25%
EPS Next 3Y42.28%
5. Dividend
5.1 Amount
With a yearly dividend of 0.82%, 1LLY is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.04, 1LLY has a dividend in line with its industry peers.
With a Dividend Yield of 0.82, 1LLY pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
5.2 History
On average, the dividend of 1LLY grows each year by 15.60%, which is quite nice.
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 36.46% of its income as dividend. This is a sustainable payout ratio.
1LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP36.46%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
BIT:1LLY (9/4/2025, 7:00:00 PM)
635.6
+5.7 (+0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap601.57B
Analysts81.21
Price Target764.85 (20.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.82% |
Yearly Dividend4.23
Dividend Growth(5Y)15.6%
DP36.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.94%
Min EPS beat(2)9.38%
Max EPS beat(2)14.51%
EPS beat(4)3
Avg EPS beat(4)2.5%
Min EPS beat(4)-20.34%
Max EPS beat(4)14.51%
EPS beat(8)7
Avg EPS beat(8)31.01%
EPS beat(12)10
Avg EPS beat(12)22.08%
EPS beat(16)12
Avg EPS beat(16)15.86%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)4.72%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)1.54%
PT rev (1m)-12.09%
PT rev (3m)-14.43%
EPS NQ rev (1m)3.53%
EPS NQ rev (3m)2.97%
EPS NY rev (1m)5.23%
EPS NY rev (3m)5.27%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)4.87%
Revenue NY rev (1m)2.9%
Revenue NY rev (3m)3.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.83 | ||
| Fwd PE | 24.25 | ||
| P/S | 13.16 | ||
| P/FCF | N/A | ||
| P/OCF | 64.06 | ||
| P/B | 38.34 | ||
| P/tB | 106.25 | ||
| EV/EBITDA | 30.28 |
EPS(TTM)13.87
EY2.18%
EPS(NY)26.22
Fwd EY4.12%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)9.92
OCFY1.56%
SpS48.31
BVpS16.58
TBVpS5.98
PEG (NY)0.6
PEG (5Y)2.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROCE | 36.25% | ||
| ROIC | 29.63% | ||
| ROICexc | 31.43% | ||
| ROICexgc | 39.29% | ||
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.4 | ||
| Cap/Depr | 580.51% | ||
| Cap/Sales | 20.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 6.72 |
F-Score6
WACC9.9%
ROIC/WACC2.99
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
EPS Next Y76.85%
EPS Next 2Y53.25%
EPS Next 3Y42.28%
EPS Next 5Y30.54%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
Revenue Next Year36.89%
Revenue Next 2Y27.13%
Revenue Next 3Y23.54%
Revenue Next 5Y17.75%
EBIT growth 1Y67.12%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year84.34%
EBIT Next 3Y42.93%
EBIT Next 5Y30.03%
FCF growth 1Y-101.56%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y75.24%
OCF growth 3Y6.69%
OCF growth 5Y12.76%